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Abstract
This is the fourth and final study designed to develop International Classification of Functioning, Disability and Health 
(ICF, and children and youth version, ICF-CY) core sets for attention-deficit hyperactivity disorder (ADHD). To investigate 
aspects of functioning and environment of individuals with ADHD as documented by the ICF-CY in clinical practice set-
tings. An international cross-sectional multi-centre study was applied, involving nine units from eight countries: Denmark, 
Germany, India, Italy, Portugal, Saudi Arabia, Sweden and Taiwan. Clinicians and clinical researchers rated the functioning 
level of 112 children, adolescents and adults with ADHD using the extended ICF-CY checklist version 2.1a. The ratings 
were based on a variety of information sources, such as medical records, medical history, clinical observations, clinical 
questionnaires, psychometric tests and structured interviews with participants and family members. In total, 113 ICF-CY 
categories were identified, of which 50 were related to the activities and participation, 33 to environmental factors and 30 
to body functions. The clinical study also yielded strengths related to ADHD, which included temperament and personality 
functions and recreation and leisure. The study findings endorse the complex nature of ADHD, as evidenced by the many 
functional and contextual domains impacted in ADHD. ICF-CY based tools can serve as foundation for capturing various 
functional profiles and environmental facilitators and barriers. The international nature of the ICF-CY makes it possible to 
develop user-friendly tools that can be applied globally and in multiple settings, ranging from clinical services and policy-
making to education and research.
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Background
Attention-deficit hyperactivity disorder (ADHD) is a neu-
rodevelopmental condition behaviourally defined by patterns 
of persistent age inappropriate inattention, hyperactivity and 
impulsivity [1], affecting 3–7% of children and adults world-
wide [2–5]. ADHD is also characterized by cognitive diffi-
culties [6], and impacts significantly on management of daily 
routines [7], school [8], work [9] and social relationships 
[10]. In addition, ADHD is associated with an increased 
risk for other neurodevelopmental and psychiatric conditions 
[11, 12], poorer quality of life [13], and premature mor-
tality [14]. Despite these negative outcomes in individual 
functioning, reports also suggest that there may be specific 
strengths related to ADHD, such as creativity and hyper-
focusing [15, 16], although these have not been documented 
consistently by research [17, 18]. Other studies have found 
certain personality features, such as inspiration and feelings 
of togetherness, to facilitate coping strategies in individuals 
with ADHD [19]. Supportive factors in the environment, 
such as special education programs and pharmacological 
treatments, have been shown to reduce challenges in ADHD 
[20, 21], while lack of support and negative attitudes from 
family members often result in increased behavioural prob-
lems [22]. To standardize the assessment of functioning 
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and environmental influences in individual cases of ADHD 
in clinical, research and educational settings, it would be 
helpful to have internationally, accepted classification tools 
available. The World Health Organization (WHO) Interna-
tional Classification of Functioning, Disability and Health 
(ICF) can serve as foundation for developing such tools [23]. 
Officially endorsed by the WHO in 2001, the ICF aims to 
provide a comprehensive, universally accepted framework 
to describe health-related functioning in different conditions 
and condition groups. In 2007, a Child and Youth version 
of the ICF, the ICF-CY, was specifically designed to cap-
ture functional aspects in developing individuals by adding 
and expanding on the descriptions of already existing ICF-
categories [24].
The ICF-CY is based on a bio-psycho-social model of 
functioning, which conceptualizes functioning and disability 
as the outcome of complex interactions between health con-
ditions and contextual factors (environmental and personal 
factors). The ICF-CY provides detailed classifications of the 
components of body functions (i.e., physiological functions 
of body systems), body structures (i.e., anatomical parts 
of the body), activities (i.e., execution of tasks), participa-
tion (i.e., involvement in life situations), and environmental 
factors (i.e., physical, social and attitudinal environment). 
The components are divided into different chapters, which 
provide a general overview of the areas of functioning and 
environment that are covered by the nomenclature. For each 
of these chapters, aspects of functioning and environment 
can be described in three levels of increasing detail, as dem-
onstrated by the following activities and participation com-
ponent example:
• Level 1 chapter: d7 Interpersonal interactions and rela-
tionships
• Level 2 category: d710 Basic interpersonal interactions
• Level 3 category: d7104 Social cues in relationships
• Level 4 category: d71040 Initiating social interactions
The ICF-CY framework also includes personal factors 
that are inherent to the individual, but not part of the indi-
vidual’s primary health condition, such as race, gender, age, 
educational level and coping styles. Personal factors are not 
specifically coded in the ICF-CY, partly because of the large 
social and cultural variability associated with them [23, 24], 
but also due to a lack of consensus on how to classify them 
and what kind of factors that would be appropriate to be 
included in the nomenclature [25]. However, there have 
been attempts to classify personal factors into categori-
cal codes. For example, Grotkamp et al. [26] proposed to 
structure 72 personal factors into 6 different chapters. The 
ICF-CY, which includes all ICF-categories, plus additional 
ones for children and youth, consists of 1685 categories 
(531 body functions; 329 body structures; 552 activities 
and participation categories; and 273 environmental factors). 
The classification provides a comprehensive, common and 
universal language for clinicians and researchers to docu-
ment and measure functional health across the lifespan for 
diagnostic, treatment and reimbursement purposes [27, 28]. 
However, using all the categories of the ICF-CY to describe 
an individual with a specific diagnosis is time-consuming 
and essentially inappropriate, as many categories may not 
apply to a person with a certain condition. To address this 
issue, the development of ICF Core Sets was initiated by 
providing shortlists of categories that are relevant to specific 
health conditions and health-related settings. The develop-
ment of Core Sets comprises four preparatory studies, 
namely a clinical study (current study, “clinical perspec-
tive”), a scoping literature review (“research perspective”), 
an expert survey (“expert perspective”) and a qualitative 
study (“client and social environment perspective”). This 
development process follows a rigorous scientific procedure 
that involves a wide range of professionals and stakeholders 
across all WHO-regions [29]. The present study is there-
fore part of a larger systematic effort that will subsequently 
lead to the development of standardized ICF Core Sets for 
ADHD. As part of this project, ICF Core Sets are also being 
developed for Autism Spectrum Disorder (ASD), with the 
results reported in separate publications [30–33].
The objective of this study was to capture functional and 
contextual features in individuals with ADHD as assessed by 
the ICF-CY in a clinical practice setting. For this purpose, 
an international cross-sectional multi-centre study was con-
ducted, involving clinicians and clinical researchers evaluat-
ing the functional level of children, adolescents and adults 
with ADHD, as well as environmental barriers and facilita-
tors and ADHD-related strengths.
Methods
Design and procedure
The study was approved by the regional ethics review board 
in Stockholm and by local ethics review boards at each of the 
participating sites. Written consent was obtained from each 
participant and/or parent or legal guardian prior to study 
participation, depending on age and communication skills. 
The consent form assured voluntarily study participation and 
confidentiality. An international cross-sectional, multi-centre 
design, as recommended by the WHO and ICF Research 
Branch, was chosen for this study, and involved nine clini-
cal units from eight countries across four WHO-regions: 
Denmark (Europe), Germany (two sites) (Europe), India 
(South-East Asia), Italy (Europe), Portugal (Europe), Saudi 
Arabia (Eastern Mediterranean), Sweden (Europe) and Tai-
wan (Western Pacific). This broad composition of countries 
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was deliberately chosen, given that cross-cultural effects 
have been found to influence attitudes, assessment and treat-
ment of ADHD [34]. Participating sites were specialized 
in the management of neurodevelopmental disorders. The 
ICF-CY rating was made based on information from medi-
cal records and history taking, clinical questionnaires (e.g., 
Conners Rating Scale, Behavior Rating Inventory of Exec-
utive Function), psychometric test scores (e.g., Wechsler 
Intelligence Scale for Children and Adults, Conners Con-
tinuous Performance Test), clinical observations and inter-
views with the participant and/or caregivers depending on 
age and developmental level of the rated case. In case there 
was any discordant information from the different sources, 
the investigators were asked to rely on their clinical judg-
ment. Each clinical investigator checked available medical 
information for each participant prior to the interviews and 
extracted information on socio-demography, co-morbidity 
and ADHD-related functioning aspects. The investigators 
then proceeded to interview the participant and/or caregiv-
ers to rate the remaining ICF-CY categories of the checklist. 
The interviews lasted between 25 and 120 min. Telephone 
interviews were occasionally used as an option to accom-
modate logistical challenges, but also to comply with some 
participants’ wishes to be interviewed via the phone.
Participants
In total, N = 119 participants fulfilled criteria for participa-
tion and consented to take part in the study between March 
and August 2016. Inclusion criteria were having a primary 
clinical diagnosis of ADHD (along with any given common 
co-morbidity, if applicable) according to local or national 
guidelines and the diagnostic criteria of the ICD-10, DSM-
IV/TR or DSM-5 and/or receiving treatment for ADHD. 
Participants were excluded from the study if the caregiver 
or the individual diagnosed with ADHD could not commu-
nicate in their country’s native language. Recruitment of 
participants was mainly conducted at the respective clini-
cal unit led by the clinical investigators in charge. Most of 
the adults (n = 39) were, however, recruited via local and 
national interest organizations for ADHD. For most of these 
adult cases, access to medical records was limited and the 
rating of functioning level was based primarily on interview 
information. Following previous ICF clinical studies for 
Core Sets development [35, 36], this study aimed to enroll 
at least 100 participants.
WHO‑ICF‑CY checklist
The WHO-ICF Checklist 2.1a [37] is a tool to elicit and 
record information on individual health-related functioning 
using selected categories from the ICF-CY. The checklist 
comprises 123 second-level ICF-CY categories across all 
four ICF-CY components: 31 body functions, 12 body struc-
tures, 48 activities and participation, and 32 environmental 
factors. Moreover, the checklist also includes diagnostic 
information, which enables users to explore the relation-
ship between a health condition and associated functioning 
problems. ICF qualifiers are usually applied to rate the cat-
egories in the checklist. The qualifiers represent a 5-point 
scale that defines severity of functional impact as how often 
a specific problem is present in an individual’s daily life. 
Previous studies have investigated the validity of the ICF 
checklist [38–40]. The feasibility of the checklist has been 
shown in patients diagnosed with different kinds of condi-
tions, including psychiatric ones, such as depression [38]. 
For the current study, an extended version of the WHO-ICF 
Checklist version 2.1a was used to rate functional abilities 
and disabilities in individuals with ADHD [see Supplemen-
tary Material]. The specificity of the checklist content was 
increased by including additional 30 ICF-CY categories (12 
body functions; 14 activities and participation; 4 environ-
mental factors) that were found to be important in ADHD 
based on the previous three preparatory studies; a compre-
hensive scoping review [41], an expert survey [15] and a 
qualitative study [16]. The checklist was divided into four 
parts. Part 1 listed the inclusion criteria of the study; part 2 
captured the socio-demographics of the participant; part 3 
included ratings of 153 ICF-CY categories; part 4 explored 
personal factors. An adapted version of the Numeric Rating 
Scale (NRS) was used to rate each ICF-CY category in the 
checklist. The NRS [42], which has been validated and com-
monly used to assess pain intensity [42], utilizes an 11-point 
scale, with 0 representing “no”, 1–3 “mild”, 4–6 “moderate” 
and 7–10 “severe symptoms/impairments”. For this study, 
clinical investigators at each respective study site rated func-
tional abilities and disabilities according to the NRS, follow-
ing the same metrics as stated above, i.e., “0” representing 
no functional disability and “7–10” severe functional dis-
ability. The primary reason for using the NRS in this study 
was because of its relative simplicity and ease of administra-
tion and scoring [43]. While the ICF qualifiers define impact 
of functional impairment as how often a specific problem is 
experienced in daily life, the NRS does not offer a specific 
definition on how to assess functional impairment. Instead, 
it enables users to explore other factors that may impact the 
individual’s functional level, such as degree and duration 
of impairment. In addition, ICF qualifiers have also been 
reported to be difficult to interpret by specific stakeholders 
[44]. The categories in the environmental factors were also 
rated according to the NRS, but with 0 representing “no 
barrier or facilitator”, + 10 “complete facilitator” and − 10 
“complete barrier”. For all the components in the checklist, 
additional scoring options of “Not applicable” and “Not 
specified” were added. “Not applicable” was used if a spe-
cific ICF-CY category was not applicable to the individual 
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(e.g., sexual functions in children), while the “Not specified” 
option was applied if there was not sufficient information 
to rate the specific category. An option to capture potential 
strengths was also included in the checklist and these were 
rated according to the NRS. A strength was defined as a 
specific ability that an individual with ADHD is better at 
compared to the average population. Information from the 
assessments that indicated potential strengths (e.g., above-
average test scores or notes from clinical observations) was 
used for this purpose. To minimize the possibility of over 
or underestimation of disabilities or strengths, the investi-
gators were instructed to ask participants for examples and 
clarifications. Functioning aspects that were not included 
in the checklist, but deemed important to ADHD, were also 
documented and rated according to the NRS. The selected 
153 second-level ICF-CY categories were distributed across 
all four ICF-CY components in the checklist as follows: 62 
body functions, 43 activities and participation categories, 36 
environmental factors and 12 body structures. The checklist 
also included an empty page for investigators to document 
any personal factors that were considered (either by the diag-
nosed individual or caregiver) to impact daily life function-
ing of ADHD. The personal factors, which were not rated, 
could either support or hamper the individual’s functional 
level. These were documented descriptively in the interviews 
with the participant and/or caregiver.
Data analysis
Any ICF-CY category that was rated with “2” or more in at 
least 10% of the cases was included as candidate category for 
the core set development. Although a scoring of “1” would 
be enough to classify a specific aspect of functioning or 
environmental factor as “mildly impaired/barrier/facilitator”, 
a more conservative cut-off was chosen to avoid margins of 
error (e.g., a specific challenge might exist in daily life, but 
not be significantly impairing enough to affect functioning 
level). The choice of a 10% cut-off was based on results 
from previous ICF clinical studies [45], and it was also used 
for ratings indicating strengths. Absolute (n) and relative 
(%) frequencies of difficulties and strengths are reported. 
Ratings that indicated “Not applicable” or “Not specified” 
were excluded from the frequency analyses. The partici-
pants’ socio-demographic background was summarized 
using descriptive statistics. Personal factors were linked to 
second-level categories as classified by Grotkamp et al. [26].
Quality assurance
Prior to study participation, each participating study site 
was required to take part in a web-based ICF self-learning 
course (http://icf.idead ay.de/). The course included an intro-
duction to the ICF, its rationale and application areas. The 
aim of the course was twofold. First, to help the investiga-
tors understand the ICF model and classification terms used 
in the nomenclature. Second, to acquaint the investigators 
with applying the ICF in practice. The investigators were 
required to pass all the training modules in the ICF course 
with 100% accuracy. Once the course was completed, the 
investigators received examples of questions that they could 
use for the interviews with the participants. Each second-
level ICF-CY category in the checklist was provided with 
clear definitions and examples, helping the investigators 
to get familiar with the checklist content. Skype meetings 
were arranged to discuss specific ICF-CY categories that 
were unclear. The checklist content was translated into the 
languages of each participating study site, with the excep-
tion of Denmark, which used an English version. The study 
coordinator (S.M.) had regular contact with the study sites, 
monitoring their progress and providing material for qual-
ity management and comparability (e.g., sending interview 
experiences from other study sites).
Sample
Of the 119 participants who were eligible for participation, 
112 completed the study. Attrition in 7 cases was due to not 
showing up for assessment (n = 4), or subsequently declin-
ing to participate in the study (n = 3) after initial consent. 
Table 1 shows the number of participants by country. Table 2 
summarizes the socio-demographics of the participants who 
were included in the final analysis with respect to age, gender, 
marital status, education background, occupational status and 
living situation. Combined ADHD was the most frequent sub-
type (n = 76, 68%), followed by the predominantly inattentive 
subtype (n = 25, 22%), predominantly hyperactive-impulsive 
subtype (n = 4, 4%) and unspecified ADHD (n = 1, 1%). In 
six participants (5%), the ADHD subtype had not been speci-
fied. The majority of the participants (n = 62, 55%) reported 
having at least one additional diagnosis. The most frequently 
reported co-morbidities were neurodevelopmental disorders 
(e.g., ASD, motor tics, communication disorders; n = 25, 
22%), mood disorders (e.g., depression, anxiety, obsessive 
Table 1  Participants by country and WHO-regions
Country WHO-region N (%)
Sweden Europe 48 (43)
Taiwan Western Pacific 24 (21)
Germany (Dres-
den + Marburg)
Europe 14 (13)
Saudi Arabia Eastern Mediterranean 9 (8)
Italy Europe 6 (5)
Portugal Europe 6 (5)
India South East Asia 4 (4)
Denmark Europe 1 (1)
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compulsive disorder, bipolar disorder; n = 17, 15%), external-
izing behaviour problems (e.g., conduct disorder, oppositional 
defiant disorder; n = 10, 9%) and learning disorders (e.g., dys-
lexia, dysgraphia, dyscalculia; n = 7, 6%).
Results
ICF‑CY category ratings
In total, 113 ICF-CY categories were identified that met 
the 10% cut-off. Data saturation [46] showed that no 
candidate category would have been lost if only European 
data would have been included. The categories were dis-
tributed across three of the four ICF-CY components: 50 
categories from the activities and participation component, 
33 environmental factors and 30 body functions. No body 
structure categories reached the cut-off. Table 3 shows 
the second-level categories that were captured in the dif-
ferent components, along with their absolute and relative 
frequencies. Categories in the activities and participation 
component were spread across all of the nine chapters, i.e., 
d1 learning and applying knowledge (k = 12), d5 self-care 
(k = 7), d7 interpersonal interactions and relationships 
Table 2  Socio-demographic 
variables of participating 
children, adolescents and adults 
with ADHD
a Other marital status includes dating, long-distance relationships, live-apart, etc
b Other educational level includes preschool and folk high school
c Other living situation includes living with a friend or grandparent, residential care, etc
Socio-demographic variables N (%) Gender (female/
male) N (%)
Age M (SD) range
Age group
 Children with ADHD (age: 6–12 years) 51 (46) 7/44
(14/86)
9.0 (1.8)
6–12
 Adolescents with ADHD (age: 13–17 years) 17 (15) 4/13
(24/76)
14.3 (1.6)
13–17
 Adults with ADHD (age: 18+ years) 44 (39) 29/15
(66/34)
37.3 (11.7)
18–61
Marital status
 Single 82 (73)
 Married 13 (12)
In domestic relationship 6 (5)
Divorced/separated 3 (3)
Other marital  statusa 8 (7)
Education level
 Primary/high school studies 80 (71)
 Higher education (e.g., college or university) 23 (21)
 Vocational education 3 (3)
 Other education  levelb 6 (5)
Working status
 Student 67 (59)
 Full-time employment 19 (16)
 Combined forms of employment 9 (8)
 Receiving benefit grants 4 (4)
 Part-time employment 3 (3)
 Sick leave 3 (3)
 Unemployment 3 (3)
 Self-employment 2 (2)
 Sickness benefits 1 (1)
 Volunteer work 1 (1)
Living situation
 Living with parents 65 (59)
 Living with partner 19 (16)
 Living independently 18 (16)
 Other living  situationc 10 (9%)
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Table 3  Absolute and relative frequencies of identified ICF-CY categories from the activities and participation, environmental factors and body 
functions components
Second-level category ICF-CY chapter N (%)
Activities and participation
 d110 Watching d1 Learning and applying knowledge 16 (14)
 d115 Listening d1 Learning and applying knowledge 29 (25)
 d140 Learning to read d1 Learning and applying knowledge 27 (24)
 d145 Learning to write d1 Learning and applying knowledge 26 (23)
 d150 Learning to calculate d1 Learning and applying knowledge 29 (25)
 d160 Focusing attention d1 Learning and applying knowledge 102 (91)
 d161 Directing attention d1 Learning and applying knowledge 102 (91)
 d166 Reading d1 Learning and applying knowledge 46 (41)
 d170 Writing d1 Learning and applying knowledge 46 (41)
 d172 Calculating d1 Learning and applying knowledge 50 (44)
 d175 Solving problems d1 Learning and applying knowledge 58 (51)
 d177 Making decisions d1 Learning and applying knowledge 59 (52)
 d210 Undertaking a single task d2 General tasks and demands in life 72 (64)
 d220 Undertaking multiple tasks d2 General tasks and demands in life 91 (81)
 d230 Carrying out daily routine d2 General tasks and demands in life 80 (71)
 d240 Handling stress and other psychological demands d2 General tasks and demands in life 74 (66)
 d250 Managing one’s own behaviour d2 General tasks and demands in life 77 (68)
 d310 Communicating with—receiving—spoken messages d3 Communication 31 (27)
 d315 Communicating with—receiving—nonverbal messages d3 Communication 32 (28)
 d330 speaking d3 Communication 32 (28)
 d335 Producing nonverbal messages d3 Communication 20 (17)
 d350 Conversation d3 Communication 55 (49)
 d440 fine Hand use d4 Mobility 34 (30)
 d446 Fine foot use d4 Mobility 20 (17)
 d470 Using transportation d4 Mobility 15 (13)
 d475 Driving d4 Mobility 22 (19)
 d510 Washing oneself d5 Self-care 26 (23)
 d520 Caring for body parts d5 Self-care 34 (30)
 d530 Toileting d5 Self-care 20 (17)
 d540 Dressing d5 Self-care 18 (16)
 d550 Eating d5 Self-care 18 (16)
 d570 Looking after one’s health d5 Self-care 52 (46)
 d571 Looking after one’s safety d5 Self-care 49 (43)
 d620 Acquisition of goods and services d6 Domestic life 35 (31)
 d630 Preparing meals d6 Domestic life 31 (27)
 d640 Doing housework d6 Domestic life 51 (45)
 d660 Assisting others d6 Domestic life 25 (22)
 d710 Basic interpersonal interactions d7 Interpersonal interactions and relationships 54 (48)
 d720 Complex interpersonal interactions d7 Interpersonal interactions and relationships 71 (63)
 d730 Relating with strangers d7 Interpersonal interactions and relationships 23 (20)
 d740 Formal relationships d7 Interpersonal interactions and relationships 37 (33)
 d750 Informal social relationships d7 Interpersonal interactions and relationships 38 (33)
 d760 Family relationships d7 Interpersonal interactions and relationships 44 (39)
 d770 Intimate relationships d7 Interpersonal interactions and relationships 32 (28)
 d820 School education d8 Major life areas 32 (28)
 d850 Remunerative employment d8 Major life areas 21 (18)
 d870 Economic self-sufficiency d8 Major life areas 27 (24)
 d880 Engagement in play d8 Major life areas 17 (15)
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Table 3  (continued)
Second-level category ICF-CY chapter N (%)
 d910 Community life d9 Community, social and civic life 15 (13)
 d920 Recreation and leisure d9 Community, social and civic life 42 (37)
Environmental factors
 e110 Products or substances for personal consumption e1 Products and technology 72 (64)
 e115 Products and technology for personal use in daily living e1 Products and technology 77 (68)
 e120 Products and technology for indoor and outdoor mobility 
and transportation
e1 Products and technology 29 (25)
 e125 Products and technology for communication e1 Products and technology 58 (51)
 e130 Products and technology for education e1 Products and technology 28 (25)
 e165 Assets e1 Products and technology 23 (20)
 e225 Climate e2 Natural environment and human-made changes to environment 35 (31)
 e240 Light e2 Natural environment and human-made changes to environment 42 (37)
 e250 Sound e2 Natural environment and human-made changes to environment 51 (45)
 e310 Immediate family e3 Support and relationships 95 (84)
 e315 Extended family e3 Support and relationships 38 (33)
 e320 Friends e3 Support and relationships 65 (58)
 e325 Acquaintances, peers, colleagues, neighbours and com-
munity members
e3 Support and relationships 38 (33)
 e330 People in positions of authority e3 Support and relationships 59 (52)
 e340 Personal care providers and personal assistants e3 Support and relationships 19 (16)
 e355 Health professionals e3 Support and relationships 81 (72)
 e360 Other professionals e3 Support and relationships 40 (35)
 e410 Individual attitudes of immediate family members e4 Attitudes 88 (78)
 e420 Individual attitudes of friends e4 Attitudes 56 (50)
 e425 Individual attitudes of acquaintances, peers, colleagues, 
neighbours and community members
e4 Attitudes 36 (32)
 e440 Individual attitudes of personal care providers and personal 
assistants
e4 Attitudes 15 (13)
 e450 Individual attitudes of health professionals E4 Attitudes 71 (63)
 e455 Individual attitudes of other professionals e4 Attitudes 29 (25)
 e460 Societal attitudes E4 Attitudes 53 (47)
 e465 Social norms, practices and ideologies e4 Attitudes 51 (45)
 e535 Communication services, systems and policies e5 Services, systems and policies 40 (35)
 e540 Transportation services, systems and policies e5 Services, systems and policies 13 (11)
 e550 Legal services, systems and policies e5 Services, systems and policies 19 (16)
 e570 Social security services, systems and policies e5 Services, systems and policies 28 (25)
 e575 General social support services, systems and policies e5 Services, systems and policies 18 (16)
 e580 Health services, systems and policies e5 Services, systems and policies 77 (68)
 e585 Education and training services, systems and policies e5 Services, systems and policies 33 (29)
 e590 Labour and employment services, systems and policies e5 Services, systems and policies 25 (22)
Body functions
 b114 Orientation functions b1 Mental functions 32 (28)
 b122 Global psychosocial functions b1 Mental functions 53 (47)
 b125 Dispositions and intra-personal functions b1 Mental functions 67 (59)
 b126 Temperament and personality functions b1 Mental functions 61 (54)
 b130 Energy and drive functions b1 Mental functions 64 (57)
 b134 Sleep functions b1 Mental functions 49 (43)
 b140 Attention functions b1 Mental functions 108 (96)
 b144 Memory functions b1 Mental functions 71 (63)
 b147 Psychomotor functions b1 Mental functions 63 (56)
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(k = 7), d2 general tasks and demands (k = 5), d3 com-
munication (k = 5), d4 mobility (k = 4), d6 domestic life 
(k = 4), d8 major life areas (k = 4) and d9 community, 
social and civic life (k = 2). The three most identified 
second-level categories in the activities and participation 
component were d160 focusing attention (n = 102, 91%), 
d161 directing attention (n = 102, 91%) and d220 under-
taking multiple tasks (n = 91, 81%). 
Environmental factors were identified in all five chap-
ters, i.e., e3 support and relationships (k = 8), e4 attitudes 
(k = 8), e5 services, systems and policies (k = 8), e1 prod-
ucts and technology (k = 6) and e2 natural environment 
and human-made changes to environment (k = 3). The 
three most identified second-level categories included 
e310 immediate family (n = 95, 84%), e410 individual 
attitudes of immediate family members (n = 88, 78%) and 
e355 health professionals (n = 81, 72%).
Of the eight chapters included in the body functions 
component, six were represented in this study. A large 
majority of the categories came from b1 mental functions 
(k = 16). Other categories were from b2 sensory functions 
and pain (k = 4), b7 neuromusculoskeletal and movement-
related functions (k = 4), b5 functions of the digestive, 
metabolic and endocrine systems (k = 3), b3 voice and 
speech functions (k = 1), b4 functions of the cardiovas-
cular, haematological, immunological and respiratory 
systems (k = 1) and b6 genitourinary and reproductive 
functions (k = 1). The three most identified second-level 
categories in the body functions component were all from 
chapter b1 mental functions, namely b140 attention func-
tions (n = 108, 96%), b164 higher-level cognitive func-
tions (n = 79, 70%) and b152 emotional functions (n = 75, 
66%).
ADHD‑related strengths
Table 4 presents the frequencies of second-level ICF-CY 
categories that were rated as strengths in individuals with 
ADHD. Of the 22 ICF-CY categories that were identified 
as strengths, 19 were from chapters in the activities and 
participation component: d7 interpersonal interactions 
and relationships (k = 4), d1 learning and applying knowl-
edge (k = 3), d4 mobility (k = 3), d6 domestic life (k = 3), 
d9 community, social and civic life (k = 3), d8 major life 
areas (k = 2) and d3 communication (k = 1). The remaining 
categories originated from b1 mental functions chapter in 
the body functions component. The three most identified 
strengths were b126 temperament and personality functions 
(n = 27, 24%), d920 recreation and leisure (n = 21, 18%) 
and b125 dispositions and intra-personal functions (n = 20, 
17%). 
Table 3  (continued)
Second-level category ICF-CY chapter N (%)
 b152 Emotional functions b1 Mental functions 75 (66)
 b156 Perceptual functions b1 Mental functions 24 (21)
 b160 Thought functions b1 Mental functions 50 (44)
 b163 Basic cognitive functions b1 Mental functions 30 (26)
 b164 Higher-level cognitive functions b1 Mental functions 79 (70)
 b167 Mental functions of language b1 Mental functions 34 (30)
 b180 Experience of self and time functions b1 Mental functions 46 (41)
 b230 Hearing functions b2 Sensory functions and pain 12 (10)
 b235 Vestibular functions b2 Sensory functions and pain 21 (18)
 b265 Touch function b2 Sensory functions and pain 27 (24)
 b280 Sensation of pain b2 Sensory functions and pain 34 (30)
 b330 Fluency and rhythm of speech functions b3 Voice and speech functions 27 (24)
 b440 Respiration functions b4 FUNCTIONS of the cardiovascular, hematological, immuno-
logical and respiratory systems
12 (10)
 b525 Defecation functions b5 Functions of the digestive, metabolic and endocrine systems 13 (11)
 b530 Weight maintenance functions b5 Functions of the digestive, metabolic and endocrine systems 29 (25)
 b535 Sensations associated with the digestive system b5 Functions of the digestive, metabolic and endocrine systems 20 (17)
 b640 Sexual functions b6 Genitourinary and reproductive functions 18 (16)
 b710 Mobility of joint functions b7 Neuromusculoskeletal and movement-related functions 14 (12)
 b735 Muscle tone functions b7 Neuromusculoskeletal and movement-related functions 27 (24)
 b760 Control of voluntary movement functions b7 Neuromusculoskeletal and movement-related functions 33 (29)
 b765 Involuntary movement functions b7 Neuromusculoskeletal and movement-related functions 17 (15)
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Personal factors
Table 5 summarizes the personal factor categories covered 
in this study. In total, 212 meaningful concepts were iden-
tified and linked to 30 second-level personal factors. The 
categories represented five of six chapters, namely i4 atti-
tudes, basic skills and behaviour patterns (k = 12), i3 mental 
factors (k = 9), i5 life situation and socioeconomic/socio-
cultural factors (k = 7), i1 general personal characteristics 
(k = 1) and i6 other health factors (k = 1). Personal factors 
can either positively or negatively impact the living experi-
ences of ADHD. The five most recurring codes consisted 
of i436 empowerment (i.e., self-motivation, endurance), 
i330 affability (i.e., willingness to cooperate, altruism), 
i350 intelligence-related factors (i.e., comprehension, IQ), 
i433 methodical skills (i.e., creativity, coping-skills), and 
i525 financial situation (i.e., gainful employment, property 
holdings).
Discussion
This international cross-sectional clinical study is the final 
preparatory study to develop ICF Core Sets for ADHD. We 
recruited individuals with ADHD from nine clinical units 
across eight countries and four WHO-regions. As expected, 
the most commonly identified difficulties in the activities 
and participation component were related to tasks and 
actions that required attention. Other commonly identified 
restrictions included undertaking multiple tasks (i.e., initi-
ating and completing multiple tasks in sequence or simul-
taneously) and carrying out daily routines (i.e., managing 
time, planning activities). Various aspects of learning and 
applying knowledge (i.e., making decisions, solving prob-
lems) were also recurrently identified as challenges. The 
main environmental factors varied from attitudes and sup-
port from immediate family members or health profession-
als (i.e., doctors, psychologists) to usage of products and 
technology in daily living (i.e., cell-phones, timers). Not 
surprisingly, many mental functions were covered in this 
study. Other body functions identified were gastro-intestinal 
issues, hypersensitivity problems and motor coordination 
difficulties. Strengths associated with ADHD included dif-
ferent temperament and personality functions (i.e., agreea-
bleness, openness to experience, optimism), participation 
in recreation and leisure activities (i.e., socializing, hob-
bies), and dispositions and intra-personal functions (i.e., 
persistence, activity level). Personal factors were broadly 
mentioned in this study, ranging from creativity, affability 
and empowerment to financial situation, social skills and 
prior experiences of traumas or injuries.
Table 4  Absolute and relative 
frequencies of ICF-CY 
categories related to ADHD-
strengths
Second-level category ICF-CY chapter N (%)
b126 Temperament and personality functions b1 Mental functions 27 (24)
d920 Recreation and leisure d9 Community, social and civic life 21 (18)
b125 Dispositions and intra-personal functions b1 Mental functions 20 (17)
d750 Informal social relationships d7 Interpersonal interactions and relationships 20 (17)
d660 Assisting others d6 Domestic life 19 (16)
d760 Family relationships d7 Interpersonal interactions and relationships 18 (16)
d175 Solving problems d1 Learning and applying knowledge 16 (14)
d630 Preparing meals d6 Domestic life 15 (13)
b144 Memory functions b1 Mental functions 14 (12)
d110 Watching d1 Learning and applying knowledge 14 (12)
d335 Producing nonverbal messages d3 Communication 14 (12)
d740 Formal relationships d7 Interpersonal interactions and relationships 14 (12)
d880 Engagement in play d8 Major life areas 14 (12)
d950 Political life and citizenship d9 Community, social and civic life 14 (12)
d161 Directing attention d1 Learning and applying knowledge 13 (11)
d450 Walking d4 Mobility 13 (11)
d455 Moving around d4 Mobility 13 (11)
d475 Driving d4 Mobility 13 (11)
d640 Doing housework d6 Domestic life 13 (11)
d930 Religion and spirituality d9 Community, social and civic life 13 (11)
d730 Relating with strangers d7 Interpersonal interactions and relationships 12 (10)
d810 Informal education d8 Major life areas 12 (10)
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Identified ICF‑CY categories
This study yielded a large number and variety of ICF-CY 
categories across three of four components and twenty 
ICF-CY chapters. Besides neuropsychological func-
tions, the impact of ADHD also broadened out to include 
other areas of body functions, such as sensory, motor and 
gastro-intestinal issues. The association between ADHD 
and motor coordination difficulties has previously been 
established in research [47]. The same is true for gastro-
intestinal problems [48] and hypersensitivity to sensory 
stimuli [49]. Although the current research literature and 
expert opinions stress the importance of treating co-mor-
bid conditions in the ADHD population, physical prob-
lems are still rarely targeted or appropriately addressed 
by service providers [50]. The bio-psycho-social model of 
the ICF-CY can bridge this gap by offering a comprehen-
sive framework that enables diverse range of functioning 
profiles to be captured and measured for diagnostic and 
treatment purposes. Treating co-morbid somatic condi-
tions in ADHD can yield successful clinical outcomes, as 
it may help individuals reduce self-blame and facilitate the 
process of self-control [51]. The clinical heterogeneity of 
ADHD is further attested by the fact that categories were 
identified from all nine chapters in the activities and par-
ticipation component. Consistent with previous research 
and the operationalization of ADHD, this study supported 
difficulties in general demands of life, social relationships 
and school [7–10, 52]. These challenges could be described 
here in more detail through the use of the IC-CY stand-
ardized system. This standardized system can serve to 
facilitate multidisciplinary assessments by enabling more 
efficient communication between different professionals 
and organizations. Corroborating our own research [15, 
16, 41], this study identified relevant environmental fac-
tors across different chapters of the ICF-CY, highlighting 
Table 5  Personal factors that either hamper or support ADHD functioning (as classified by Grotkamp et al. 2012)
Second-level category Chapter N
i120 Sex i1 General personal characteristics 1
i310 Extraversion i3 Mental factors 5
i315 Factors of emotionality i3 Mental factors 6
i320 Reliability i3 Mental factors 5
i325 Openness to new experiences i3 Mental factors 6
i330 Affability i3 Mental factors 7
i335 Self-confidence i3 Mental factors 4
i340 Optimism i3 Mental factors 5
i350 Intelligence-related factors i3 Mental factors 7
i355 Cognitive factors i3 Mental factors 3
i410 World view i4 Attitudes 2
i416 Attitude toward health and disease i4 Attitudes 3
i419 Attitude toward intervention and health-related assistance i4 Attitudes 1
i428 Attitude toward help i4 Attitudes 4
i430 Social skills i4 Attitudes 6
i433 Methodical skills i4 Attitudes 7
i436 Empowerment i4 Attitudes 18
i439 Proaction i4 Attitudes 5
i442 Media skills i4 Attitudes 1
i453 Habitual use of stimulants i4 Attitudes 3
i456 Exercise habits i4 Attitudes 2
i459 Relaxation habits i4 Attitudes 1
i510 Living arrangements i5 Life situation and socioeconomic/sociocultural factors 5
i515 Accommodation arrangements i5 Life situation and socioeconomic/sociocultural factors 1
i520 Employment situation i5 Life situation and socioeconomic/sociocultural factors 2
i525 Financial situation i5 Life situation and socioeconomic/sociocultural factors 7
i530 Socioeconomic status i5 Life situation and socioeconomic/sociocultural factors 2
i540 Belonging to groups in society i5 Life situation and socioeconomic/sociocultural factors 2
i550 Educational status i5 Life situation and socioeconomic/sociocultural factors 2
i610 Prior diseases, health impairments, injuries or traumas i5 Life situation and socioeconomic/sociocultural factors 4
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the importance of taking into account all types of facili-
tators and barriers in the environment when conducting 
functional assessments related to ADHD. One of the most 
referenced chapters in the environmental factors compo-
nent was attitudes, which might be explained by the fact 
that ADHD is still not fully accepted as a bona-fide medi-
cal condition among some community members [53, 54]. 
In fact, previous research has shown that individuals with 
ADHD encounter negative experiences accessing care due 
to skeptical attitudes towards ADHD by health profession-
als and a lack of expertise in the area [55]. Another envi-
ronmental chapter that was frequently covered in this study 
was support and relationships, which contains information 
on people or animals that provide practical, physical or 
emotional support to individuals. Given the large number 
of countries that were included in this study, it is not sur-
prising that different types of supportive individuals were 
identified. Environmental facilitators and barriers can vary 
substantially depending on region and culture [34]. For 
example, a lack of support from extended family members 
might not have too great of an impact on functioning in 
highly individualized societies compared to those based on 
a more collectivistic culture, where large groups of families 
tend to live close to each other. Broad variation of services 
was also captured in this study, ranging from health care 
providers and special education interventions to labour 
employment and social security programs. Despite the 
extensive impact of ADHD on individual functioning, there 
is still a growing demand for services that can be offered 
in addition to pharmacological treatments [56]. The need 
for non-pharmacological interventions can be explained by 
numerous reasons. First, although pharmacological treat-
ments are efficacious and widely used [21], its long-term 
effectiveness remains to be established [57]. Second, non-
adherence to medication has been observed in some indi-
viduals with ADHD who experience adverse side effects, 
including mood instability, heart palpation, nausea and 
anxiety [58]. Third, some parents may have reservations 
about psychopharmacological treatments [59]. Our results 
underpin the importance of delivering adequate services 
in multiple clinical, educational and community settings 
to optimize ADHD outcome in individuals with ADHD. 
Interestingly, this study also yielded categories related to 
the immediate physical individual environment, such as 
light and sound. These physical factors in the environment 
seem more essential in clinical settings to individuals with 
ADHD and their caregivers compared to existing research 
literature [41] and expert opinions [15]. No body structures 
were identified in this study when using clinical records 
and the ICF-CY Checklist for their assessment. Neverthe-
less, detailed physical or neurological examinations were 
not conducted, as they are currently not an integral inter-
national standard of diagnosing ADHD.
ADHD‑related strengths
This is to our knowledge the first international clini-
cal study that investigated strengths in individuals with 
ADHD using the ICF-CY framework. The strengths cap-
tured were quite broad and variable, reflecting the het-
erogeneity of ADHD presentation. Some participants 
mentioned that their ADHD made it easier for them to be 
open to new experiences and try new things in life. Others 
emphasized the role that ADHD played in taking initiative 
to create new hobbies or participate in social events. Con-
trary to the expert survey and qualitative study [15, 16], 
this study identified new aspects of strengths in ADHD, 
such as making friends and having good relationships with 
family members. Some participants mentioned that they 
were able to form meaningful social relationships with 
their loved ones after many years of practice and learning, 
while others felt that ADHD made it automatically easier 
for them to approach people and initiate meaningful inter-
actions that later led to deeper social bonds. The strengths 
identified in the current study can, in combination with the 
results from the expert survey [15] and qualitative study 
[16], lead to future novel hypotheses for research, where 
the topic of ADHD-related strengths can be more com-
prehensively explored. Focusing on strengths in ADHD 
research can be beneficial for future clinical care, enabling 
assessments that capture the entire spectrum of function-
ing, including not only specific individual disabilities, but 
also strengths. Taking into account strengths can balance-
out deficit and resource-oriented views of ADHD in inter-
vention and increase general societal awareness.
Personal factors
Although a diagnosis of ADHD requires the symptoms to 
significantly impair daily life functioning, there is a consid-
erable knowledge gap in how diagnosed individuals experi-
ence their own involvement and engagement in everyday 
activities. Investigating personal factors, defined by the 
WHO as particular features of an individual’s life that are 
inherent to the individual, but not part of the condition, are 
therefore crucial for the understanding of ADHD in daily 
life. Participants mentioned many personal factors to either 
hamper or facilitate their functioning. For example, empow-
erment, which involves drive functions and goal-oriented 
actions, was reported to aid to cope with hardships, enable 
academic and vocational success. Finding motivation and 
setting personal goals were mentioned to positively influ-
ence coping-skills and personal development, which is in 
line with previous qualitative research on ADHD [19]. Fur-
ther, a positive attitude toward the ADHD diagnosis was 
experienced as a protective factor in life. Several participants 
acknowledged past traumatic events (i.e., getting bullied, 
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losing a loved one) and current life-habits (i.e., lack of physi-
cal activity, drinking alcohol) to clearly hamper individual 
functioning. Altogether, the results demonstrate the neces-
sity to not only explore diagnostic status according to ICD 
and ICF classified functioning aspects, but also personal fac-
tors in ADHD to fully grasp individual situations, limitations 
and potentials.
Study limitations
The current study faced some important methodological 
challenges. Even though the current sample included cases 
from eight countries and four WHO-regions, Africa and the 
Americas were unfortunately not represented. Moreover, the 
South-East Asia region only contributed a handful of cases 
to the study sample, while the Western Pacific only included 
cases from the Far East, limiting the potential global gen-
eralization. A large proportion of the participants came 
from Europe, making it difficult to conduct cross-cultural 
comparisons within the study sample. Saturation analyses 
showed, however, that no candidate category would have 
been lost, if only data from Europe would have been ana-
lyzed. The latter indicates a good cross-cultural agreement 
and generalizability of the functional abilities and disabili-
ties typical of ADHD. The primary aim of this study was not 
to explore cultural differences in ADHD-related functioning 
and environment, but to ensure cross-cultural coverage of 
ICF-CY candidate categories when generating evidence for 
the upcoming ICF core set international consensus confer-
ence. Here, experts from all WHO-regions are represented to 
decide on the first versions of the ICF core sets for ADHD, 
and additional categories might be added based on consen-
sus, if needed. Although it is encouraged by the WHO and 
ICF Research Branch [29] to involve international stake-
holders, analyses of cultural differences are not a mandatory 
part of the core set development. However, we plan for the 
future to explore cultural differences in ADHD function-
ing and environment in a separate article by pooling data 
from the different preparatory studies. There is a substantial 
value in investigating cultural influences on ADHD, as these 
have shown to affect diagnostic assessment and treatment 
options [34, 53]. Moreover, gender and age group differ-
ences were not investigated in this study, partly because of 
the uneven representation of females and adolescents, but 
also due to many confounding factors (e.g., culture, co-
morbidity, ADHD subtype, information sources) that might 
potentially lead to biased results. Compared to children and 
adolescents, the ICF-CY checklist for adults with ADHD in 
this study were mainly completed without having full access 
to medical records, possibly limiting the depths of clinical 
assessment of functioning in these cases. In future studies, 
it would be desirable to involve larger numbers of units spe-
cialized in adult neuropsychiatry. Interviews on children and 
adolescents relied for the most part on secondary inform-
ants (i.e., immediate family member), which is not unusual 
for child and adolescent mental health, but still might not 
be particularly representative of the primary perspective of 
young individuals diagnosed with ADHD. Even though pri-
mary informants are preferable, there are some challenges 
with using self-reports in younger individuals with disabili-
ties. Young children may lack the understanding, insight or 
communication skills to provide valid information [13]. In 
addition, for children with mental health problems, disorder-
specific symptoms and impairments may also affect their 
own assessment [59]. For example, a child with ADHD may 
have issues with reporting on attention problems owing to 
attention problems. Additionally, this study did not investi-
gate inter-rater reliability between the investigators, mainly 
due to the international nature of the study and cultural and 
language issues associated with it. The investigators were, 
however, strictly instructed to seek consensus rating in their 
clinical teams pertaining to the cases.
Conclusions
This study examined individuals diagnosed with ADHD 
using the ICF-CY framework in clinical environments in 
eight countries and four WHO-regions. It assessed both 
abilities and disabilities commonly associated with ADHD 
across the entire lifespan, as well as environmental barriers 
and facilitators, and personal factors. The results from the 
current study complete the preparatory scientific basis for 
developing the first versions of ICF Core Sets for ADHD, 
using a formal decision-making process at a consensus con-
ference. From these Core Sets, standardized metric tools can 
be developed to enhance nuanced diagnostic documentation, 
treatment planning, and outcome research of functioning in 
individuals with ADHD. The Core Sets will also guide ICF-
CY assessments recommended for ADHD in ICD-11 (http://
apps.who.int/class ifica tions /icd11 ).
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